Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the free cash flow yield high or low?
The free cash flow yield of 186.61% is 36% above its estimated 1-year average of 137.42%, near the high end of its estimated 1-year range (110.02%–186.61%).
As of 2026-10-06T17:31:49.550Z.
Calculation as of: 2026-10-06T17:31:49.550Z.
Quote observation: 2026-10-06T17:29:56.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9199062e3d99303b6ceeba444dd11ff94fafae694fd5228a7a2e61ab73072144
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
186.61%
FREE CASH FLOW YIELD AVG TTM
N/A
FREE CASH FLOW YIELD AVG 3Y
N/A
FREE CASH FLOW YIELD AVG 5Y
N/A
FREE CASH FLOW YIELD AVG 10Y
N/A
FREE CASH FLOW YIELD AVG 15Y
N/A
FREE CASH FLOW YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.72%
median of 199 covered companies
CURRENT VS SECTOR MEDIAN
+3853.60%
vs the sector median at left
Fortress Biotech, Inc.
Market Cap
$67.43M
Free Cash Flow Yield
186.61%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$67.77M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$67.38M
Free Cash Flow Yield
N/A
TTM Avg
6.20%
3Y Avg
5.62%
5Y Avg
4.88%
Market Cap
$68.61M
Free Cash Flow Yield
28.54%
TTM Avg
14.79%
3Y Avg
25.02%
5Y Avg
20.90%
Market Cap
$66.46M
Free Cash Flow Yield
N/A
TTM Avg
24.06%
3Y Avg
24.06%
5Y Avg
24.06%
Market Cap
$71.19M
Free Cash Flow Yield
N/A
TTM Avg
0.09%
3Y Avg
0.09%
5Y Avg
0.09%
Market Cap
$64.99M
Free Cash Flow Yield
N/A
TTM Avg
2.91%
3Y Avg
2.91%
5Y Avg
2.91%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | $67.43M | 186.61% | N/A | N/A | N/A |
| Tiziana Life Sciences Ltd (TLSA)vs › | $67.77M | N/A | N/A | N/A | N/A |
| iBio, Inc. (IBIO)vs › | $67.52M | N/A | N/A | N/A | N/A |
| Champions Oncology, Inc. (CSBR)vs › | $67.38M | N/A | 6.20% | 5.62% | 4.88% |
| Spero Therapeutics, Inc. (SPRO)vs › | $68.61M | 28.54% | 14.79% | 25.02% | 20.90% |
| XBiotech Inc. (XBIT)vs › | $66.46M | N/A | 24.06% | 24.06% | 24.06% |
| MindWalk Holdings Corp. (HYFT)vs › | $71.19M | N/A | 0.09% | 0.09% | 0.09% |
| Cingulate Inc. (CING)vs › | $65.46M | N/A | N/A | N/A | N/A |
| Gossamer Bio, Inc. (GOSS)vs › | $64.99M | N/A | 2.91% | 2.91% | 2.91% |
| RenovoRx, Inc. (RNXT)vs › | $64.43M | N/A | N/A | N/A | N/A |
FCF Yield
186.61%
Earnings Yield
132.12%
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | FREE CASH FLOW YIELD |
|---|---|
| 2026-10-05 | 162.68% |
| 2026-10-02 | 167.49% |
| 2026-10-01 | 164.25% |
| 2026-09-30 | 158.88% |
| 2026-09-29 | 154.55% |
| 2026-09-28 | 156.68% |
| 2026-09-25 | 149.12% |
| 2026-09-24 | 149.12% |
| 2026-09-23 | 145.30% |
| 2026-09-22 | 138.78% |
| 2026-09-21 | 141.08% |
| 2026-09-18 | 135.46% |
| 2026-09-17 | 135.46% |
| 2026-09-16 | 138.21% |
| 2026-09-15 | 136.55% |
| 2026-09-14 | 134.39% |
| 2026-09-11 | 134.92% |
| 2026-09-10 | 132.30% |
| 2026-09-09 | 129.28% |
| 2026-09-08 | 125.46% |
| 2026-09-04 | 125.00% |
| 2026-09-03 | 125.46% |
| 2026-09-02 | 124.54% |
| 2026-09-01 | 126.87% |
| 2026-08-31 | 124.09% |
| 2026-08-28 | 122.74% |
| 2026-08-27 | 121.43% |
| 2026-08-26 | 121.00% |
| 2026-08-25 | 120.14% |
| 2026-08-24 | 116.04% |
| 2026-08-21 | 118.47% |
| 2026-08-20 | 122.74% |
| 2026-08-19 | 119.30% |
| 2026-08-18 | 116.84% |
| 2026-08-17 | 120.57% |
| 2026-08-14 | 116.04% |
| 2026-08-13 | 137.71% |
| 2026-08-12 | 149.23% |
| 2026-08-11 | 157.23% |
| 2026-08-10 | 149.23% |
| 2026-08-07 | 153.70% |
| 2026-08-06 | 148.15% |
| 2026-08-05 | 147.09% |
| 2026-08-04 | 150.87% |
| 2026-08-03 | 148.69% |
| 2026-07-31 | 131.11% |
| 2026-07-30 | 124.73% |
| 2026-07-29 | 122.50% |
| 2026-07-28 | 121.06% |
| 2026-07-27 | 125.50% |
| 2026-07-24 | 122.87% |
| 2026-07-23 | 119.64% |
| 2026-07-22 | 115.60% |
| 2026-07-21 | 116.25% |
| 2026-07-20 | 123.24% |
| 2026-07-17 | 122.14% |
| 2026-07-16 | 119.99% |
| 2026-07-15 | 110.61% |
| 2026-07-14 | 110.02% |
| 2026-07-13 | 124.36% |
| 2026-07-10 | 124.36% |
| 2026-07-09 | 124.73% |
| 2026-07-08 | 136.79% |
| 2026-07-07 | 137.25% |
| 2026-07-06 | 139.11% |
| 2026-07-02 | 134.99% |
| 2026-07-01 | 132.81% |
| 2026-06-30 | 134.11% |
| 2026-06-29 | 139.11% |
| 2026-06-26 | 148.69% |
| 2026-06-25 | 135.89% |
| 2026-06-24 | 130.69% |
| 2026-06-23 | 129.87% |
| 2026-06-22 | 133.24% |
| 2026-06-18 | 137.25% |
| 2026-06-17 | 133.67% |
| 2026-06-16 | 140.06% |
| 2026-06-15 | 143.49% |
| 2026-06-12 | 148.15% |
| 2026-06-11 | 148.69% |
| 2026-06-10 | 148.15% |
| 2026-06-09 | 140.06% |
| 2026-06-08 | 143.99% |
| 2026-06-05 | 154.86% |
| 2026-06-04 | 148.15% |
| 2026-06-03 | 157.23% |
| 2026-06-02 | 154.86% |
| 2026-06-01 | 159.68% |
| 2026-05-29 | 146.56% |
| 2026-05-28 | 146.04% |
| 2026-05-27 | 148.69% |
| 2026-05-26 | 152.56% |
| 2026-05-22 | 149.77% |
| 2026-05-21 | 147.62% |
| 2026-05-20 | 154.86% |
| 2026-05-19 | 162.20% |
| 2026-05-18 | 165.47% |
| 2026-05-15 | 170.28% |
